Patent ID: 9707271
Date: 2017-07-18
CPC Classifications: A61K,A61P,C07K

Claim:
1. A method for enhancing engraftment of a cardiac cell or progenitor thereof, the method comprising contacting the cardiac cell or progenitor thereof with a composition comprising (a) one or more of connective tissue growth factor (CTGF) having at least 95% amino acid sequence identity to SEQ ID NO: 1 and human C-terminal CTGF peptide having at least 95% amino acid sequence identity to SEQ ID NO: 2 or 3; and (b) one or more of insulin comprising polypeptides having at least 95% amino acid sequence identity to SEQ ID NOs: 6 and 7 and IGF-1 having at least 95% amino acid sequence identity to SEQ ID NO: 8, thereby enhancing engraftment.